Clinical Data Management
The DataLabs® EDC solution is uniquely focused on simplifying workflows and delivering superior user experiences. Its advanced EDC features help streamline the entire process starting from study design all the way to collection, management and reporting of clinical trial data.
Many trials continue to use paper-driven processes even as sponsors and sites advance toward EDC adoption. The DataLabs EDC application provides a single electronic clinical data management platform to unify the functionality of paper data entry (PDE) with the flexibility of EDC. The unique hybrid capability enables studies to include sites using paper CRFs and supports existing paper processes. The method of data capture can switch at any point during the study.
Unique product convergence between DataLabs EDC and ClinPhone® RTSM applications allows site users to perform real-time randomization and dispensation activities directly with the EDC application without having to log into IVR or IWR systems. The tight interoperability with the ClinPhone RTSM solution dramatically simplifies workflows for site and sponsor users.
Available as an on-demand, software-as-a-service (SaaS) application with subscription-based pricing, it benefits customers through rapid and efficient EDC deployment without high upfront costs, system investment or ongoing maintenance issues. The DataLabs EDC solution means total flexibility and ease-of-use for customers of all types and sizes.
The DataLabs® EDC solution is uniquely focused on simplifying workflows and delivering superior user experiences. Its advanced features help streamline the entire process starting from study design all the way to collection, management and reporting of clinical trial data…
Today's clinical trials are relying on clinical endpoint adjudication, the assessment of patient events or outcomes, with increasing frequency. Clinical Endpoint Committees (CEC) are formed for a study, consisting primarily of physicians, to review all relevant documents…
Adaptive clinical trials can offer enormous potential in today's drug development process. They can facilitate better decision making by enabling more dose levels to be studied in Phase II dose-finding studies while maintaining practical sample sizes. They can also reduce the time between development…